Healthcare

Integriertes Videokonferenzsystem und viele neue, pharmaspezifische Funktionen – das sind die neuen Pluspunkte der neuen C-World-Version.

Karlsruhe, 1. Juli 2020

Pharmakon Software steht für qualitativ hochwertige Software, die die hohen Anforderungen der europäischen Life Science-Branche erfüllt und darüber hinaus in Deutschland entwickelt wird. Das CRM „C-World“ der Pharmakon Software mit seinen umfangreichen pharmaspezifischen Funktionen wird kontinuierlich im engen Kundendialog weiterentwickelt. Das neue Sommer-Release 2020 wartet nun mit 44 neuen Funktionen auf, die den Arbeitsalltag in der Pharmabranche entscheidend erleichtern. Viele Impulse der Pharmaunternehmen von der diesjährigen Kundentagung im Mai konnten so praxisorientiert umgesetzt werden.

Ein besonderes Highlight ist das integrierte Videokonferenz-System, das nun auf einfachste Weise ermöglicht, Online-Calls zu vereinbaren und freigegebene Materialien online zu präsentieren.

Konkrete Neuerungen der Sommer-Version:
 Neue Module:
 Multichannel-Marketing mit Videokonferenz
 Patientenverwaltung
 Tourenplaner
 Freigabenprozess für Spesenabrechnungen

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Sepsis Diagnostics market during the historical period of 2012 – 2016. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2017, and key prospects over the forecast period 2017 – 2026.

According to a study by Fact.MR, the global sepsis diagnostics market is expected to witness strong growth, registering 7.7% CAGR during the forecast period 2017-2026. The global sepsis diagnostics market is also projected to generate US$ 707.3 million revenue by the end of 2026.  Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the sepsis diagnostics market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the sepsis diagnostics market.

After reading the sepsis diagnostics market report, readers get insight into: 

The global Dual Chamber Prefilled Syringes Market study presents an all in all compilation of the historical, current and future outlook of the Market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Dual Chamber Prefilled Syringes Market player in a comprehensive way. Further, the Dual Chamber Prefilled Syringes Market report emphasizes the adoption pattern of the Dual Chamber Prefilled Syringes across various industries. A CAGR of 8.7% has been projected for the global dual chamber prefilled syringes market during the forecast period, 2017 to 2026, according to a new study of Fact.MR. Roughly US$ 3,300 Mn worth of dual chamber prefilled syringes are likely to be sold across the globe by 2026-end.

In this Dual Chamber Prefilled Syringes market study, the following years are considered to project the market footprint:

History Year: 2012 – 2016
Base Year: 2012
Estimated Year: 2017
Forecast Year: 2017 – 2026
After reading the Dual Chamber Prefilled Syringes market report, readers can:

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Lip Care market during the historical period of 2012 – 2016. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2017, and key prospects over the forecast period 2017 – 2026.

A new report compiled by Fact.MR has slated a value CAGR of 4.5% for the global lip care market in the forecast period (2017-2026). Over 650,000,000 units of lip care products are expected to be sold across the globe by 2026-end. Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Lip Care market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Lip Care market.

After reading the Lip Care market report, readers get insight into: 

Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection. Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=361

Fibrosarcoma has no definite cause like other sarcomas. However, most of the sarcomas are associated with the genetic mutations. Soft tissue fibrosarcoma is among rare cancer which has no exact cause but carries various risk factors. Undergoing as radiotherapy to treat other cancer is one of the factors that is increasing the risk of fibrosarcoma. Currently, there are very few ways to treat fibrosarcoma with complications involved. Hence, researchers and research institutes around the world are researching for some very effective treatments. Targeted therapies are also being focused on to treat fibrosarcoma. There are also many anti-angiogenesis agents under development and few are in clinical trials. Chemotherapy for soft tissue sarcoma usually involves a combination of various drugs. Hence, companies are researching on new drugs effective in treating soft tissue sarcoma.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=353

The global plasmapheresis market is likely to grow at a steady CAGR of over 7% during the forecast period 2017-2026, and reach a valuation of over US$ 1.5 Bn by the end of 2026. The market is likely to be impacted by a range of macro-economic and micro-economic factors. Increasing emphasis on upgrading healthcare infrastructure, combined with higher awareness on treating thrombotic thrombocytopenic purpura (TTP) and autoimmune diseases are the key factors that will lead to increasing adoption of plasmapheresis as a first line of treatment.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=351

In several emergency cases, oral doctors and maxillofacial surgeons are being called on in the hospitals to check the common case of nose-bleeding. This condition, medically known as epistaxis, has been one of the common pains for people through the age. Increasing exposure to physical traumas and harsh environment continue to factor the incidence of epistaxis across the globe. From physical assault to entry of foreign particles, epistaxis can be caused from a range of factors, increasing the need for appropriate and easily available medicine. Manufacturers of drugs are actively developing improved drugs on epistaxis to help people control persistent bleeding from the nose. A recently-published report by Fact.MR projects that in 2017, nearly US$ 150 Mn worth of epistaxis medicine and drugs will be sold across the globe.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=344

Growing prevalence of breast cancer is projected to rev up demand for tissue expanders globally. Moreover, increasing demand for reconstruction of face, neck and forehead due to injuries is projected to impact the global market growth of tissue expanders positively. Fact.MR states that the global market of tissue expanders is projected to reflect a CAGR of 6.9% over the forecast period, 2017-2026.

Factors Fuelling Growth of the Global Market     

Growth of the global tissue expanders market is mainly bound to various macro-economic and micro-economic factors. Increasing number of breast removal attributed to breast cancer surgeries is projected to rev up demand for tissue expanders globally. World Cancer Research Fund states that breast cancer accounts for nearly 25% of the new cases of cancer and is a common type of cancer globally. Growing need to improve the aesthetic beauty is further expected to contribute towards the global market growth of tissue expanders. Breast tissue expanders continue to remain increasingly preferred and highly popular clinical option among the customers.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=340

For the forecast period, 2017 to 2026, Fact.MR has projected a moderate expansion for the global orthopedic power tools market in its recent report. Global sales of orthopedic power tools are estimated to reach approximately US$ 2,500 Mn in revenues by 2026-end.

Prominent Manufacturers Engaging in Orthopedic Power Tools’ Safety & Ergonomics

Recent increase in the global geriatric population has led toward a rise in incidences of orthopedic diseases, which require surgical intervention, thereby fuelling demand for orthopedic power tools. The advent of modern electronic technologies including power-assisted, robotic, and minimally invasive orthopedic surgery equipment have further escalated adoption of orthopedic power tools. Although orthopedic power tools offer inherent benefits, surgeons are exposed to risks related to the prolonged use of vibrating tools, hazards pertaining to aerosol/ droplet infection from patients, and protracted exposure to loud noise. Prominent manufacturers have therefore been actively engaging in aspects of orthopedic power tools’ safety and ergonomics, in a bid to develop a range of power-assisted equipment tailored to the precision of the procedure’s nature, while addressing efficacy and safety of surgeons.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=334